Cargando…

Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients

BACKGROUND: Septic shock is commonly treated in the emergency department (ED) with vasopressors. Prior data have shown that vasopressor administration through a peripheral intravenous line (PIV) is feasible. OBJECTIVES: To characterize vasopressor administration for patients presenting to an academi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilian, Scott, Surrey, Aaron, McCarron, Weston, Mueller, Kristen, Wessman, Brian Todd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973174/
https://www.ncbi.nlm.nih.gov/pubmed/36864853
http://dx.doi.org/10.5005/jp-journals-10071-24243
_version_ 1784898466506342400
author Kilian, Scott
Surrey, Aaron
McCarron, Weston
Mueller, Kristen
Wessman, Brian Todd
author_facet Kilian, Scott
Surrey, Aaron
McCarron, Weston
Mueller, Kristen
Wessman, Brian Todd
author_sort Kilian, Scott
collection PubMed
description BACKGROUND: Septic shock is commonly treated in the emergency department (ED) with vasopressors. Prior data have shown that vasopressor administration through a peripheral intravenous line (PIV) is feasible. OBJECTIVES: To characterize vasopressor administration for patients presenting to an academic ED in septic shock. MATERIALS AND METHODS: Retrospective observational cohort study evaluating initial vasopressor administration for septic shock. ED patients from June 2018 to May 2019 were screened. Exclusion criteria included other shock states, hospital transfers, or heart failure history. Patient demographics, vasopressor data, and length of stay (LOS) were collected. Cases were grouped by initiation site: PIV, ED placed central line (ED-CVL), or tunneled port/indwelling central line (Prior-CVL). RESULTS: Of the 136 patients identified, 69 were included. Vasopressors were initiated via PIV in 49%, ED-CVL in 25%, and prior-CVL in 26%. The time to initiation was 214.8 minutes in PIV and 294.7 minutes in ED-CVL (p = 0.240). Norepinephrine predominated all groups. No extravasation or ischemic complications were identified with PIV vasopressor administration. Twenty-eight-day mortality was 20.6% for PIV, 17.6% for ED-CVL, and 61.1% for prior-CVL. Of 28-day survivors, ICU LOS was 4.44 for PIV and 4.86 for ED-CVL (p = 0.687), while vasopressor days were 2.26 for PIV and 3.14 for ED-CVL (p = 0.050). CONCLUSION: Vasopressors are being administered via PIVs for ED septic shock patients. Norepinephrine comprised the majority of initial PIV vasopressor administration. There were no documented episodes of extravasation or ischemia. Further studies should look at the duration of PIV administration with potential avoidance of central venous cannulation altogether in appropriate patients. HOW TO CITE THIS ARTICLE: Kilian S, Surrey A, McCarron W, Mueller K, Wessman BT. Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients. Indian J Crit Care Med 2022;26(7):811–815.
format Online
Article
Text
id pubmed-9973174
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-99731742023-03-01 Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients Kilian, Scott Surrey, Aaron McCarron, Weston Mueller, Kristen Wessman, Brian Todd Indian J Crit Care Med Original Article BACKGROUND: Septic shock is commonly treated in the emergency department (ED) with vasopressors. Prior data have shown that vasopressor administration through a peripheral intravenous line (PIV) is feasible. OBJECTIVES: To characterize vasopressor administration for patients presenting to an academic ED in septic shock. MATERIALS AND METHODS: Retrospective observational cohort study evaluating initial vasopressor administration for septic shock. ED patients from June 2018 to May 2019 were screened. Exclusion criteria included other shock states, hospital transfers, or heart failure history. Patient demographics, vasopressor data, and length of stay (LOS) were collected. Cases were grouped by initiation site: PIV, ED placed central line (ED-CVL), or tunneled port/indwelling central line (Prior-CVL). RESULTS: Of the 136 patients identified, 69 were included. Vasopressors were initiated via PIV in 49%, ED-CVL in 25%, and prior-CVL in 26%. The time to initiation was 214.8 minutes in PIV and 294.7 minutes in ED-CVL (p = 0.240). Norepinephrine predominated all groups. No extravasation or ischemic complications were identified with PIV vasopressor administration. Twenty-eight-day mortality was 20.6% for PIV, 17.6% for ED-CVL, and 61.1% for prior-CVL. Of 28-day survivors, ICU LOS was 4.44 for PIV and 4.86 for ED-CVL (p = 0.687), while vasopressor days were 2.26 for PIV and 3.14 for ED-CVL (p = 0.050). CONCLUSION: Vasopressors are being administered via PIVs for ED septic shock patients. Norepinephrine comprised the majority of initial PIV vasopressor administration. There were no documented episodes of extravasation or ischemia. Further studies should look at the duration of PIV administration with potential avoidance of central venous cannulation altogether in appropriate patients. HOW TO CITE THIS ARTICLE: Kilian S, Surrey A, McCarron W, Mueller K, Wessman BT. Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients. Indian J Crit Care Med 2022;26(7):811–815. Jaypee Brothers Medical Publishers 2022-07 /pmc/articles/PMC9973174/ /pubmed/36864853 http://dx.doi.org/10.5005/jp-journals-10071-24243 Text en Copyright © 2022; Jaypee Brothers Medical Publishers (P) Ltd. https://creativecommons.org/licenses/by-nc/4.0/© The Author(s). 2022 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Article
Kilian, Scott
Surrey, Aaron
McCarron, Weston
Mueller, Kristen
Wessman, Brian Todd
Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients
title Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients
title_full Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients
title_fullStr Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients
title_full_unstemmed Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients
title_short Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients
title_sort vasopressor administration via peripheral intravenous access for emergency department stabilization in septic shock patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973174/
https://www.ncbi.nlm.nih.gov/pubmed/36864853
http://dx.doi.org/10.5005/jp-journals-10071-24243
work_keys_str_mv AT kilianscott vasopressoradministrationviaperipheralintravenousaccessforemergencydepartmentstabilizationinsepticshockpatients
AT surreyaaron vasopressoradministrationviaperipheralintravenousaccessforemergencydepartmentstabilizationinsepticshockpatients
AT mccarronweston vasopressoradministrationviaperipheralintravenousaccessforemergencydepartmentstabilizationinsepticshockpatients
AT muellerkristen vasopressoradministrationviaperipheralintravenousaccessforemergencydepartmentstabilizationinsepticshockpatients
AT wessmanbriantodd vasopressoradministrationviaperipheralintravenousaccessforemergencydepartmentstabilizationinsepticshockpatients